The CD44 receptor is a molecular predictor of survival in ovarian cancer

Author： Rodríguez-Rodríguez L.   Sancho-Torres I.   Mesonero C.   Gibbon D.   Shih W.   Zotalis G.  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.20, Iss.3, 2003-09, pp. : 255-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD44 variant expression and estrogen receptor status in breast cancer

By Hole A.K.   Belkhiri A.   S. Snell L.   Watson P.H.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 2, 1997-04 ,pp. : 165-173

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival

By Halon Agnieszka  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 511-518

Springer Publishing Company

Access to resources Recommend Favorite

Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan

By Catterall J.B.   Jones L.M.H.   Turner G.A.  

Clinical and Experimental Metastasis, Vol. 17, Iss. 7, 1999-09 ,pp. : 583-591

Springer Publishing Company

Access to resources Recommend Favorite

CD44v6 promotes β-catenin and TGF-β expression, inducing aggression in ovarian cancer cells

By                    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3505-3510

Spandidos Publications

Access to resources Recommend Favorite

Expression of CD44 in Uterine Cervical Squamous Neoplasia: A Predictor of Microinvasion?

By Callagy G.   O'Grady A.   Butler D.   Leader M.   Kay E.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite